Literature DB >> 14623520

Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways.

Wei Yue1, Ji-Ping Wang, Mark R Conaway, Yuebai Li, Richard J Santen.   

Abstract

Long-term estrogen deprivation causes hypersensitivity of MCF-7 cells to the mitogenic effect of estradiol (E2) which is associated with activation of mitogen-activated protein kinase (MAPK). However, several lines of evidence indicate that MAPK activation is not the exclusive mechanism for E2 hypersensitivity and multiple signal pathways might be involved. The current study explores the possible role of the PI3 kinase (PI3K) pathway in development of E2 hypersensitivity. Basal PI3K activity in long-term estrogen deprived MCF-7 cells (LTED) was elevated as evidenced by increased phosphorylation of three downstream effectors, Akt, p70 S6 kinase, and eukaryotic initiation factor-4E binding protein (4E-BP1), which was blocked by the specific inhibitor of PI3K, LY294002. Dual blockade of both MAPK and PI3K completely reversed E2 hypersensitivity of LTED cells. Enhancement in aromatase activity is another phenomenon accompanied with E2 hypersensitivity. In aromatase over-expressing MCF-7 cells, aromatase activity was reduced by inhibitors of MAPK and PI3K suggesting the involvement of protein phosphorylation in the regulation of aromatase activity. Our data suggest that in addition to the MAP kinase pathway, activation of the PI3 kinase pathway is involved in E2 hypersensitivity, which develops during adaptation of MCF-7 cells to the low estrogen environment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623520     DOI: 10.1016/s0960-0760(03)00366-2

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  23 in total

1.  Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.

Authors:  Todd W Miller; Bryan T Hennessy; Ana M González-Angulo; Emily M Fox; Gordon B Mills; Heidi Chen; Catherine Higham; Carlos García-Echeverría; Yu Shyr; Carlos L Arteaga
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  COX-2 inhibitor nimesulide analogs are aromatase suppressors in breast cancer cells.

Authors:  Bin Su; Xiaohan Cai; Yanyan Hong; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2010-06-11       Impact factor: 4.292

Review 3.  Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells.

Authors:  Richard J Santen; Robert X Song; Shigeru Masamura; Wei Yue; Ping Fan; Tetsuya Sogon; Shin-ichi Hayashi; Kei Nakachi; Hidtek Eguchi
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 4.  Optimizing the use of neoadjuvant endocrine therapy.

Authors:  Laila S Agrawal; Ingrid A Mayer
Journal:  Curr Oncol Rep       Date:  2015-07       Impact factor: 5.075

5.  Everolimus in combination with letrozole inhibit human breast cancer MCF-7/Aro stem cells via PI3K/mTOR pathway: an experimental study.

Authors:  Yan Liu; Xiaobei Zhang; Jingjing Liu; Guofang Hou; Sheng Zhang; Jin Zhang
Journal:  Tumour Biol       Date:  2013-09-08

6.  Growth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms.

Authors:  Bin Su; Cynthie Wong; Yanyan Hong; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-26       Impact factor: 4.292

7.  Sensitivity to the aromatase inhibitor letrozole is prolonged after a "break" in treatment.

Authors:  Gauri Sabnis; Olga Goloubeva; Rabia Gilani; Luciana Macedo; Angela Brodie
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

8.  Aromatase is phosphorylated in situ at serine-118.

Authors:  Todd W Miller; Incheol Shin; Norio Kagawa; Dean B Evans; Michael R Waterman; Carlos L Arteaga
Journal:  J Steroid Biochem Mol Biol       Date:  2008-09-04       Impact factor: 4.292

9.  Lead optimization of COX-2 inhibitor nimesulide analogs to overcome aromatase inhibitor resistance in breast cancer cells.

Authors:  Bin Su; Shiuan Chen
Journal:  Bioorg Med Chem Lett       Date:  2009-10-03       Impact factor: 2.823

10.  Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells.

Authors:  Wei Yue; Ping Fan; Jiping Wang; Yuebai Li; Richard J Santen
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.